WAVE Life Sciences Ltd diskutieren
WAVE Life Sciences Ltd
WKN: A1436W / Symbol: WVE / Name: WAVE Life / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
?
0,89 %
WAVE Life Sciences (NASDAQ:WVE) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its price target lowered by analysts at Wells Fargo & Company from $18.00 to $16.00. They now have an "overweight" rating on the stock.
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Wedbush from $18.00 to $20.00. They now have an "outperform" rating on the stock.
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Cantor Fitzgerald from $12.00 to $34.00. They now have an "overweight" rating on the stock.
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its "buy" rating reaffirmed by analysts at B. Riley.
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) was given a new $50.00 price target on by analysts at Truist Financial Corporation. They now have a "buy" rating on the stock.
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Cantor Fitzgerald from $34.00 to $41.00. They now have an "overweight" rating on the stock.
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $38.00 price target on the stock.
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (WVE) had its "buy" rating reaffirmed by HC Wainwright. They now have a $30.00 price target on the stock.
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (WVE) had its price target raised by Wedbush from $33.00 to $35.00. They now have an "outperform" rating on the stock.
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (WVE) had its price target raised by Canaccord Genuity Group Inc. from $43.00 to $52.00. They now have a "buy" rating on the stock.
Ratings data for WVE provided by MarketBeat
Neueste Beiträge
UBS_Group_AG in Casella Waste Sys A diskutieren